Our Platform
A complete cancer intelligence infrastructure — from screening devices to AI analytics to verifiable health credentials to mobile fleet operations.
Screening is how we acquire data.
Intelligence is what we sell.
Mandiera HealthTech is not a screening company. It is a data and AI intelligence company. Cancer screening is the data acquisition mechanism. The MCRI™ risk score is the product. The dataset is the asset that compounds in value every quarter.
Track 1 — Insured Population (Revenue)
Fixed clinics, hospitals, and corporate wellness venues. Patient pays nothing — Mandiera bills their medical aid scheme directly. Scan price: $24–$35. Cost: $8.10. Gross margin: 76.9%.
Track 2 — Pink Pulse™ Free Screening (Data)
Uninsured and rural communities. Zero cost to patient. Funded by corporate CSR and government contracts. Generates geographically diverse dataset that is commercially irreplaceable.
Core Platform Components
OncoDetect™
FDA-cleared, non-invasive cancer screening devices deployed across fixed clinics, corporate venues, and Pink Pulse™ mobile units. No radiation. No specialist required. Results in 5 minutes.
MedIntelligence™
Transforms raw scan data into the MCRI™ (Mandiera Cancer Risk Index) — Africa's first population-level cancer risk score. Licensed to insurers, governments, and pharmaceutical companies at enterprise SaaS pricing ($270K–$1.1M/year per contract).
HealthPass™
A blockchain-signed certificate of verified cancer screening status. Issued immediately after every scan. Presented by the patient as a QR code. Verified by insurers via API (returns valid/invalid only — no clinical data shared). Expires every 6 months, creating a recurring screening cycle.
When insurers and employers require HealthPass™ as a condition of cover or employment, it becomes Africa's de facto cancer credentialing standard — with compounding network effects.
Pink Pulse™ Mobile Fleet
Pink Pulse Defender
Land Rover Defender 130 diesel. Solar array + Starlink satellite connectivity. Privacy gazebo. Serves areas unreachable by standard vehicles. 600–880 scans/month.
Pink Pulse Vito
Mercedes Vito Mixto 4MATIC. Compact urban unit for corporate campuses, peri-urban communities, and medical aid wellness days. 880–1,320 scans/month.
Revenue Streams
| Stream | Pricing | Timeline |
|---|---|---|
| Per-Scan Fees (Track 1) | $24–$35 per scan · 76.9% gross margin | Live via Vision World SA. Scales from Month 1. |
| MCRI™ Analytics SaaS | $270K–$1.1M / year per enterprise client | Year 2+. Insurers + governments. |
| HealthPass™ Certificates | $5.40 per certificate issued | Year 1. Volume-driven. |
| Pharma Data Licensing | $250K–$1M per cohort | Year 2+. 50,000+ scan dataset required. |
| Corporate Wellness | Per-employee annual contract | Live. Vision World SA base. |
| Pink Pulse™ CSR | $27K–$65K per unit per year | Year 1. Co-sponsorship from corporates. |
Deployment Roadmap
South Africa
iBreastExam™. Insurer billing live. MCRI™ first reports. Track 1 revenue begins.
SADC Entry
CervAIcal™ + OrCA™. Pink Pulse™ fleet launch. Zimbabwe + Botswana. First govt contracts.
East Africa
RaKSA™ triple-cancer. Enterprise SaaS. Pharma licensing. Kenya, Tanzania, Uganda.
Genomics
DNA from DBS cards. Ethics-approved biobank. Africa genomics database. Cape to Cairo.